摘要
目的探讨醒脑静联合无创通气治疗肺性脑病的临床疗效。方法将58例患者应用醒脑静注射液联合无创通气治疗3~5 d后观察疗效。结果 50例有效,与对照组比较有显著差异。结论醒脑静联合无创通气治疗肺性脑病疗效确切,毒副作用少。
Objective Research into the clinical effect of Xingnaojing Combined non-invasive ventilation in the treatment of pulmonary encephalopathy.Methods 58 patients were treated with XNJI combined non-invasive ventilation treatment effects were observed 3~5 days later.Results 50 cases effective,and the control group were significantly different.Conclusion Xingnaojing Combined non-invasive ventilation in the treatment of pulmonary encephalopathy is effective,side effects.
出处
《临床肺科杂志》
2011年第2期237-238,共2页
Journal of Clinical Pulmonary Medicine
关键词
醒脑静注射液
无创通气
肺性脑病
临床疗效
xingnaojing Injection
non-invasive ventilation
pulmonary encephalopathy clinical effect